HIP1403

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HIP1403, covering 2016-10-13 to 2016-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions [Phase 1]